lobbying_activities: 759180

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
759180	05cc7365-91e9-4c77-b24a-8147365f6bcc	Q1	AMYLIN PHARMACEUTICALS	308536	AMYLIN PHARMACEUTICALS	2009	first_quarter	PHA	S. 301, Physician Payments Sunshine Act of 2009 H.R. 1548, Pathway for Biosimilars Act H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act S. 726, Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation/Drug Safety H.R. 759, Food and Drug Administration Globalization Act of 2009	Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		350000	0	0	2009-04-17T16:29:46-04:00